Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 19Small Cell Lung Carcinoma 10Lung Neoplasms 10Squamous Cell Carcinoma of Head and Neck 8Cholangiocarcinoma 7Pancreatic Neoplasms 6Ovarian Neoplasms 6Oropharyngeal Neoplasms 6Fallopian Tube Neoplasms 6Urinary Bladder Neoplasms 5Breast Neoplasms 5Uterine Cervical Neoplasms 4Gallbladder Neoplasms 4Brain Neoplasms 4Adenocarcinoma of Lung 4Stomach Neoplasms 3Sarcoma 3Mouth Neoplasms 3Mesothelioma, Malignant 3Laryngeal Neoplasms 3Hypopharyngeal Neoplasms 3Carcinoma 3Urethral Neoplasms 2Triple Negative Breast Neoplasms 2Testicular Neoplasms 2Seminoma 2Salivary Gland Neoplasms 2Recurrence 2Prostatic Neoplasms 2Peritoneal Neoplasms 2

Interventions

Ankle Brachial Index 2Acetylcysteine 2sodium thiosulfate 1Tomography, X-Ray Computed 1Saline Solution 1Ringer's Lactate 1Radiosurgery 1Platinum 1Ofloxacin 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Hearing Tests 1Hearing 1Genetic Association Studies 1Ear Protective Devices 1Cisplatin 1Carboplatin 1Audiometry, Pure-Tone 1Acoustic Impedance Tests 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hearing Loss × Platinum × Clear all
NCT07218913 2026-04-17

Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors

City of Hope Medical Center

Phase 1 Recruiting
44 enrolled
Genitourinary

Testicular Neoplasms, Seminoma, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡